We use cookies for a better user experience. Read our Privacy Policy
I Agree
Drug Delivery Systems Market Insights, 2017-2025
Drug Delivery Systems Market: Snapshot
Drug delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect. The global drug delivery systems market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025. Increase in demand for self-administration and home health care devices are likely to fuel expansion of the global drug delivery systems market from 2017 to 2025.
Continuous innovations in the global drug delivery systems market is creating opportunities for major and local manufacturers to develop wide product portfolio. Additionally, collaborations among major market players for superior technological advancements in drug delivery offerings is likely to drive the global drug delivery systems market during the forecast period. Using nanotechnology, the drug can be targeted to a precise location, which makes drugs more effective and reduce the chances of possible side effects. Major manufacturers operating in the market are involved in continuous research & development activities to expand their already wide product portfolio. For instance, on September 2017, Baxter International Inc. announced the launch of DeviceVue, an asset tracking system for sigma spectrum infusion system whereas, emerging players operating in the market are also focusing on introducing new versions of their existing drug delivery devices. Continuous expansion of drug delivery systems offering in high throughput along with reduced waiting time and improved result specificity are likely to drive the global drug delivery systems during the forecast period. However, high cost associated with treatment and increase in drug recalls are likely to restrain the global drug delivery systems market during the forecast period.
The global drug delivery systems market has been segmented based on delivery system, application, route of administration, and geography. In terms of delivery system, the targeted drug delivery segment is projected to continue its dominance during the forecast period followed by the polymeric drug delivery segment. Introduction of new drug delivery devices such as SmartDose wearable injector and increase in demand for targeted and low dose frequency drug delivery is likely to propel the segment. Based on application, oncology was the leading revenue generating segment in 2016 and it is likely to continue its dominance during the forecast period due to the increase in prevalence of various types of cancer. According to WHO report, in the year 2015, around 70% of cancer-related deaths occurred in low- and middle- income countries. The infectious diseases segment is likely to lose market share during the forecast period owing rise in preference to develop oncology and diabetes drug delivery system by manufactures. In terms of route of administration, injectable dominated the market in 2016 and is likely to account for a leading share during the forecast period.
Geographically, North America accounted for a leading share of the global drug delivery system market in 2016. However, rise in research & development expenses for advanced drug delivery devices in the U.S. is key concern area among key players. The market in Asia Pacific is projected to gain share during the forecast period and is likely to be key revenue generator in the next few years. Initiatives by local governments for self-sufficiency in manufacturing pharmaceuticals and prevalence of various diseases in countries such as Brazil, South Africa, Saudi Arabia, etc. are anticipated to boost market in Latin America and Middle East & Africa.
Key companies operating in the global drug delivery systems market and profiled in the report include AstraZeneca plc., Bayer AG, Pfizer, Inc., Novartis AG, Amgen Inc., Johnson and Johnson Services, Inc., Baxter International, Inc., Boston Scientific Corporation, and Becton, Dickinson & Company. These players adopt organic and in-organic growth strategies to expand their product offerings, strengthen their geographical reach, increase customer base, and garner market share. For instance, in June 30, 2017, the F. Hoffmann-La Roche Ltd. acquired mySugr, a company that is dedicated to developing applications and software for diabetes care.
The global drug delivery systems market has been segmented as follows:
|
by Type of Delivery System |
|
|
by Application |
|
|
by Route of Administration |
|
|
by Geography |
|
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
Drug delivery systems market to reach approximately US$ 900 Bn by 2025
Drug delivery systems market is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025
Drug delivery systems market is driven by increase in demand for self-administration and home health care devices
The targeted drug delivery segment is projected to continue its dominance during the forecast period
Key companies operating in the global drug delivery systems market and profiled in the report include AstraZeneca plc., Bayer AG, Pfizer, Inc., Novartis AG, Amgen Inc., Johnson and Johnson Services, Inc.
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2. Assumptions and Research Methodology
Chapter 3. Executive Summary: Global Drug Delivery Systems Market
Chapter 4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.1.2. Industry Evolution / Developments
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Pipeline Analysis - Drug Therapy Products
4.4. Porter’s Five Force Analysis
4.5. Technological Advancement in Drug Delivery Products
4.6. Regulatory Scenario
4.7. Key Mergers and Acquisitions
4.8. Global Drug Delivery Systems Market Analysis and Forecasts, 2015–2025
4.8.1. Market Revenue Projection (US$ Mn)
4.8.2. Market Outlook
Chapter 5. Global Drug Delivery Systems Market Analysis and Forecasts, by Type of Delivery System
5.1. Key Findings / Developments
5.2. Introduction & Definition
5.3. Market Value Forecast by Delivery Systems, 2016–2025
5.3.1. Intrauterine Implants
5.3.2. Prodrug Implants
5.3.3. Polymeric Drug Delivery
5.3.4. Targeted Drug Delivery
5.4. Market Attractiveness by Delivery Systems
Chapter 6. Global Drug Delivery Systems Market Analysis and Forecasts, by Application
6.1. Key Findings / Developments
6.2. Introduction & Definition
6.3. Market Value and Volume Forecast by Application, 2016–2025
6.3.1. Infectious Diseases
6.3.2. Oncology
6.3.3. Ophthalmology
6.3.4. Urology
6.3.5. Diabetes
6.3.6. CNS
6.3.7. Others
6.4. Market Attractiveness by Application
Chapter 7. Global Drug Delivery Systems Market Analysis and Forecasts, by Route of Administration
7.1. Key Findings / Developments
7.2. Introduction & Definition
7.3. Market Value and Volume Forecast by Route of Administration, 2016–2025
7.3.1. Oral
7.3.2. Injectable
7.3.3. Inhalation
7.3.4. Transdermal
7.3.5. Ocular
7.3.6. Nasal
7.3.7. Topical
7.4. Market Attractiveness by Route of Administration
Chapter 8. Global Drug Delivery Systems Market Analysis and Forecasts, by Geography / Region
8.1. Geographical Representation
8.2. Market Value and Volume Forecast by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness by Region
Chapter 9. North America Drug Delivery Systems Market Analysis and Forecast
9.1. Market Value Forecast by Country, 2017–2025
9.1.1. U.S.
9.1.2. Canada
9.2. Market Value Forecast by Type of Delivery System, 2016–2025
9.3. Market Value Forecast by Application, 2016–2025
9.4. Market Value Forecast by Route of Administration, 2016–2025
9.5. Market Attractiveness Analysis
9.5.1. by Country
9.5.2. by Type of Delivery System
9.5.3. by Application
9.5.4. by Route of Administration
Chapter 10. Europe Drug Delivery Systems Market Analysis and Forecast
10.1. Market Value Forecast by Country, 2017–2025
10.1.1. Germany
10.1.2. France
10.1.3. U.K.
10.1.4. Spain
10.1.5. Italy
10.1.6. Rest of Europe
10.2. Market Value Forecast by Type of Delivery System, 2016–2025
10.3. Market Value Forecast by Application, 2016–2025
10.4. Market Value Forecast by Route of Administration, 2016–2025
10.5. Market Attractiveness Analysis
10.5.1. by Country
10.5.2. by Type of Delivery System
10.5.3. by Application
10.5.4. by Route of Administration
Chapter 11. Asia Pacific Drug Delivery Systems Market Analysis and Forecast
11.1. Market Value Forecast by Country, 2017–2025
11.1.1. China
11.1.2. Japan
11.1.3. India
11.1.4. Australia & New Zealand
11.1.5. Rest of APAC
11.2. Market Value Forecast by Type of Delivery System, 2016–2025
11.3. Market Value Forecast by Application, 2016–2025
11.4. Market Value Forecast by Route of Administration, 2016–2025
11.5. Market Attractiveness Analysis
11.5.1. by Country
11.5.2. by Delivery Systems
11.5.3. by Application
11.5.4. by Route of Administration
Chapter 12. Latin America Drug Delivery Systems Market Analysis and Forecast
12.1. Market Value Forecast by Country, 2017–2025
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Rest of LATAM
12.2. Market Value Forecast by Type of Delivery System, 2016–2025
12.3. Market Value Forecast by Application, 2016–2025
12.4. Market Value Forecast by Route of Administration, 2016–2025
12.5. Market Attractiveness Analysis
12.5.1. by Country
12.5.2. by Delivery Systems
12.5.3. by Application
12.5.4. by Route of Administration
Chapter 13. Middle East and Africa Drug Delivery Systems Market Analysis and Forecast
13.1. Market Value Forecast by Country, 2017–2025
13.1.1. GCC Countries
13.1.2. South Africa
13.1.3. Israel
13.1.4. Rest of MEA
13.2. Market Value Forecast by Type of Delivery System, 2016–2025
13.3. Market Value Forecast by Application, 2016–2025
13.4. Market Value Forecast by Route of Administration, 2016–2025
13.5. Market Attractiveness Analysis
13.5.1. by Country
13.5.2. by Delivery Systems
13.5.3. by Application
13.5.4. by Route of Administration
Chapter 14. Competition Landscape
14.1. Competition Matrix
14.1.1. Novartis AG
14.1.2. Amgen Inc.
14.1.3. F. Hoffmann-La Roche Ltd.
14.1.4. Pfizer Inc.
14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.2.1. Novartis AG (HQ, Business Segments, Employee Strength)
14.2.1.1. Company Details
14.2.1.2. Company Description
14.2.1.3. Business Overview
14.2.1.4. SWOT Analysis
14.2.1.5. Financial Analysis
14.2.1.6. Strategic Overview
14.2.2. Amgen Inc. (HQ, Business Segments, Employee Strength)
14.2.2.1. Company Details
14.2.2.2. Company Description
14.2.2.3. Business Overview
14.2.2.4. SWOT Analysis
14.2.2.5. Strategic Overview
14.2.3. F.Hoffmann-La Roche Ltd. (HQ, Business Segments, Employee Strength)
14.2.3.1. Company Details
14.2.3.2. Company Description
14.2.3.3. Business Overview
14.2.3.4. SWOT Analysis
14.2.3.5. Strategic Overview
14.2.4. Pfizer Inc. (HQ, Business Segments, Employee Strength)
14.2.4.1. Company Details
14.2.4.2. Company Description
14.2.4.3. Business Overview
14.2.4.4. SWOT Analysis
14.2.4.5. Strategic Overview
14.2.5. Johnson & Johnson Services, ltd. (HQ, Business Segments, Employee Strength)
14.2.5.1. Company Details
14.2.5.2. Company Description
14.2.5.3. Business Overview
14.2.5.4. SWOT Analysis
14.2.5.5. Financial Analysis
14.2.5.6. Strategic Overview
14.2.6. Becton, Dickinson and Company (HQ, Business Segments, Employee Strength)
14.2.6.1. Company Details
14.2.6.2. Company Description
14.2.6.3. Business Overview
14.2.6.4. SWOT Analysis
14.2.6.5. Financial Analysis
14.2.6.6. Strategic Overview
14.2.7. AstraZeneca plc (HQ, Business Segments, Employee Strength)
14.2.7.1. Company Details
14.2.7.2. Company Description
14.2.7.3. Business Overview
14.2.7.4. SWOT Analysis
14.2.7.5. Financial Analysis
14.2.7.6. Strategic Overview
14.2.8. Baxter International, Inc. (HQ, Business Segments, Employee Strength)
14.2.8.1. Company Details
14.2.8.2. Company Description
14.2.8.3. Business Overview
14.2.8.4. SWOT Analysis
14.2.8.5. Financial Analysis
14.2.8.6. Strategic Overview
14.2.9. Bayer AG (HQ, Business Segments, Employee Strength)
14.2.9.1. Company Details
14.2.9.2. Company Description
14.2.9.3. Business Overview
14.2.9.4. SWOT Analysis
14.2.9.5. Strategic Overview
14.2.10. Boston Scientific Corporation (HQ, Business Segments, Employee Strength)
14.2.10.1. Company Details
14.2.10.2. Company Description
14.2.10.3. Business Overview
14.2.10.4. SWOT Analysis
14.2.10.5. Strategic Overview
List of Tables
Table 01: Regulatory Scenario in Different Countries
Table 02: Regulatory Scenario in Different Countries
Table 03: Drug Therapy Pipeline Products
Table 04: Global Drug Delivery Systems Market Size (US$ Bn) Forecast, by Type of Drug Delivery System, 2015–2025
Table 05: Global Drug Delivery System Market Value (US$ Bn) Forecast, by Application, 2015–2025
Table 06: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 07: Global Drug Delivery System Market Size (US$ Bn) Forecast, by Region, 2015–2025
Table 08: North America Drug Delivery System Market Size (US$ Bn) Forecast, by Country, 2015–2025
Table 09: North America Drug Delivery System Market Size (US$ Bn) Forecast, by Type of Drug Delivery System, 2015–2025
Table 10: North America Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 11: North America Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 12: Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 13: Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Type of Drug Delivery System, 2015–2025
Table 14: Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 15: Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 16: Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 17: Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Type of Drug Delivery System, 2015–2025
Table 18: Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 19: Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 20: Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 21: Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Type of Drug Delivery System, 2015–2025
Table 22: Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 23: Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 24: Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 25: Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Type of Drug Delivery System, 2015–2025
Table 26: Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 27: Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
List of Figures
Figure 01: Global Drug Delivery System Market Snapshot
Figure 02: Global Drug Delivery System Market Size, by Route of Administration (US$ Bn), 2016
Figure 03: Global Drug Delivery System Market Size (US$ Mn), by Region, 2016 and 2025
Figure 04: Global Drug Delivery System Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 05: Global Drug Delivery System Market Value Share, by Type of Route of Administration (2016)
Figure 06: Global Drug Delivery System Market Value Share, by Type of Drug Delivery System (2016)
Figure 07: Global Drug Delivery System Market Value Share, by Application (2016)
Figure 08: Global Drug Delivery Systems Market Value Share, by Type of Drug Delivery System, 2016 and 2025
Figure 09: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Type of Drug Delivery System: Intrauterine Implants, 2015–2025
Figure 10: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Type of Drug Delivery System: Prodrug Implants, 2015–2025
Figure 11: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Type of Drug Delivery System: Polymeric Drug Delivery, 2015–2025
Figure 12: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Type of Drug Delivery System: Targeted Drug Delivery, 2015–2025
Figure 13: Global Drug Delivery Systems Market Attractiveness, by Type of Drug Delivery System, 2017–2025
Figure 14: Global Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 15: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Infectious Diseases, 2015–2025
Figure 16: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Oncology, 2015–2025
Figure 17: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Ophthalmology, 2015–2025
Figure 18: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Urology, 2015–2025
Figure 19: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Diabetes, 2015–2025
Figure 20: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by CNS, 2015–2025
Figure 21: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 22: Global Drug Delivery System Market Attractiveness, by Application, 2017–2025
Figure 23: Global Drug Delivery Systems Market Value Share, by Drug Delivery: Route of Administration, 2016 and 2025
Figure 24: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2015–2025
Figure 25: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Injectable, 2015–2025
Figure 26: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Inhalation, 2015–2025
Figure 27: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Transdermal, 2015–2025
Figure 28: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Ocular, 2015–2025
Figure 29: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Nasal, 2015–2025
Figure 30: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2015–2025
Figure 31: Global Drug Delivery Systems Market Attractiveness, by Drug Delivery: Route of Administration, 2017–2025
Figure 32: Global Drug Delivery System Market Revenue (US$ Bn) Forecast, 2015–2025
Figure 33: Global Drug Delivery System Market Value Share Analysis, by Region, 2016 and 2025
Figure 34: Global Drug Delivery System Market Attractiveness, by Region, 2017–2025
Figure 35: North America Drug Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 36: North America Drug Delivery System Market Value Share Analysis, by Country, 2016 and 2025
Figure 37: North America Drug Delivery System Market Attractiveness Analysis, by Country, 2017–2025
Figure 38: North America Drug Delivery System Market Value Share Analysis, by Type of Drug Delivery System, 2016 and 2025
Figure 39: North America Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 40: North America Drug Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 41: North America Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 42: North America Drug Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 43: Europe Drug Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 44: Europe Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 45: Europe Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 46: Europe Drug Delivery System Market Value Share Analysis, by Type of Drug Delivery System, 2016 and 2025
Figure 47: Europe Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 48: Europe Drug Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 49: Europe Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 50: Europe Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 51: Asia Pacific Drug Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 52: Asia Pacific Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 53: Asia Pacific Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 54: Asia Pacific Drug Delivery System Market Value Share Analysis, by Type of Drug Delivery System, 2016 and 2025
Figure 55: Asia Pacific Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 56: Asia Pacific Drug Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 57: Asia Pacific Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 58: Asia Pacific Drug Delivery System Market Attractiveness Analysis, by Route of Administration, 2016 and 2025
Figure 59: Latin America Drug Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 60: Latin America Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 61: Latin America Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 62: Latin America Drug Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
Figure 63: Latin America Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 64: Latin America Drug Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 65: Latin America Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 66: Latin America Drug Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 67: Middle East & Africa Drug Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 68: Middle East & Africa Drug Delivery System Market Value Share Analysis, by Country/Sub-Region, 2016 and 2025
Figure 69: Middle East & Africa Drug Delivery System Market Attractiveness Analysis, by Country/Sub-Region, 2017–2025
Figure 70: Middle East & Africa Drug Delivery System Market Value Share Analysis, by Type of Drug Delivery System, 2016 and 2025
Figure 71: Middle East & Africa Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 72: Middle East & Africa Drug Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 73: Middle East & Africa Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 74: Middle East & Africa Drug Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
